%0 Journal Article
%@ 1438-8871
%I JMIR Publications
%V 22
%N 7
%P e17559
%T The Effects of Telemonitoring on Patient Compliance With Self-Management Recommendations and Outcomes of the Innovative Telemonitoring Enhanced Care Program for Chronic Heart Failure: Randomized Controlled Trial
%A Ding,Hang
%A Jayasena,Rajiv
%A Chen,Sheau Huey
%A Maiorana,Andrew
%A Dowling,Alison
%A Layland,Jamie
%A Good,Norm
%A Karunanithi,Mohanraj
%A Edwards,Iain
%+ The Australian e-Health Research Centre, Commonwealth Scientific & Industrial Research Organisation Health & Biosecurity, 343 Royal Parade, Parkville VIC 3052, Melbourne, 3052, Australia, 61 416129871, Rajiv.Jayasena@csiro.au
%K heart failure
%K digital health
%K telemonitoring
%K remote monitoring
%K patient compliance
%K randomized controlled trial
%D 2020
%7 8.7.2020
%9 Original Paper
%J J Med Internet Res
%G English
%X Background: Telemonitoring enables care providers to remotely support outpatients in self-managing chronic heart failure (CHF), but the objective assessment of patient compliance with self-management recommendations has seldom been studied. Objective: This study aimed to evaluate patient compliance with self-management recommendations of an innovative telemonitoring enhanced care program for CHF (ITEC-CHF). Methods: We conducted a multicenter randomized controlled trial with a 6-month follow-up. The ITEC-CHF program comprised the provision of Bluetooth-enabled scales linked to a call center and nurse care services to assist participants with weight monitoring compliance. Compliance was defined a priori as weighing at least 4 days per week, analyzed objectively from weight recordings on the scales. The intention-to-treat principle was used to perform the analysis. Results: A total of 184 participants (141/184, 76.6% male), with a mean age of 70.1 (SD 12.3) years, were randomized to receive either ITEC-CHF (n=91) or usual care (control; n=93), of which 67 ITEC-CHF and 81 control participants completed the intervention. For the compliance criterion of weighing at least 4 days per week, the proportion of compliant participants in the ITEC-CHF group was not significantly higher than that in the control group (ITEC-CHF: 67/91, 74% vs control: 56/91, 60%; P=.06). However, the proportion of ITEC-CHF participants achieving the stricter compliance standard of at least 6 days a week was significantly higher than that in the control group (ITEC-CHF: 41/91, 45% vs control: 23/93, 25%; P=.005). Conclusions: ITEC-CHF improved participant compliance with weight monitoring, although the withdrawal rate was high. Telemonitoring is a promising method for supporting both patients and clinicians in the management of CHF. However, further refinements are required to optimize this model of care. Trial Registration: Australian New Zealand Clinical Trial Registry ACTRN12614000916640; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366691 
%M 32673222
%R 10.2196/17559
%U https://www.jmir.org/2020/7/e17559
%U https://doi.org/10.2196/17559
%U http://www.ncbi.nlm.nih.gov/pubmed/32673222